{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:15:58Z","timestamp":1790496958434,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Scottish Rite Hospital for Children"},{"name":"JPJS KAKENHI","award":["15K08437"],"award-info":[{"award-number":["15K08437"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.joca.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T09:37:52Z","timestamp":1541324272000},"page":"326-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-2282","authenticated-orcid":false,"given":"N.","family":"Kamiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kuroyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Aruwajoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl l","key":"10.1016\/j.joca.2018.10.010_bib1","first-page":"S141","article-title":"Legg-Calve-Perthes disease: etiology, pathogenesis, and biology","volume":"31","author":"Kim","year":"2012","journal-title":"J\u00a0Pediatr Orthop"},{"key":"10.1016\/j.joca.2018.10.010_bib2","first-page":"119","article-title":"Osteoarthritis of the young adult hip: etiology and treatment","volume":"35","author":"Aronson","year":"1986","journal-title":"Instr Course Lect"},{"issue":"3","key":"10.1016\/j.joca.2018.10.010_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01202412-199907000-00002","article-title":"Significance of synovitis in Legg-Calve-Perthes disease","volume":"8","author":"Wingstrand","year":"1999","journal-title":"J\u00a0Pediatr Orthop B"},{"issue":"6","key":"10.1016\/j.joca.2018.10.010_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jbmr.2435","article-title":"Legg-Calve-Perthes disease produces chronic hip synovitis and elevation of interleukin-6 in the synovial fluid","volume":"30","author":"Kamiya","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"issue":"13","key":"10.1016\/j.joca.2018.10.010_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2106\/JBJS.15.01209","article-title":"HIF-1-Dependent IL-6 activation in articular chondrocytes initiating synovitis in femoral head ischemic osteonecrosis","volume":"98","author":"Yamaguchi","year":"2016","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"24","key":"10.1016\/j.joca.2018.10.010_bib6","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.joca.2018.10.010_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/35.4.309","article-title":"Bone mass measurement and bone metabolism in rheumatoid arthritis: a review","volume":"35","author":"Deodhar","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"11","key":"10.1016\/j.joca.2018.10.010_bib8","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"De Benedetti","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.joca.2018.10.010_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00774-013-0514-1","article-title":"IL-6 negatively regulates osteoblast differentiation through the SHP2\/MEK2 and SHP2\/Akt2 pathways in\u00a0vitro","volume":"32","author":"Kaneshiro","year":"2014","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.joca.2018.10.010_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biocel.2016.08.003","article-title":"Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption","volume":"79","author":"Sims","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.joca.2018.10.010_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bone.2018.08.011","article-title":"Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model","volume":"116","author":"Kuroyanagi","year":"2018","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.joca.2018.10.010_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"issue":"9617","key":"10.1016\/j.joca.2018.10.010_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.joca.2018.10.010_bib14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s11999-015-4172-6","article-title":"Development of a mouse model of ischemic osteonecrosis","volume":"473","author":"Kamiya","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"17","key":"10.1016\/j.joca.2018.10.010_bib15","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2174\/1381612821666150310143332","article-title":"Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedside","volume":"21","author":"Liu","year":"2015","journal-title":"Curr Pharmaceut Des"},{"issue":"1","key":"10.1016\/j.joca.2018.10.010_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/annrheumdis-2013-203559","article-title":"Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.joca.2018.10.010_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/annrheumdis-2013-204760","article-title":"Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study","volume":"73","author":"Genovese","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.joca.2018.10.010_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/art.27740","article-title":"Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants","volume":"63","author":"Smolen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.joca.2018.10.010_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bone.2012.11.023","article-title":"Acute BMP2 upregulation following induction of ischemic osteonecrosis in immature femoral head","volume":"53","author":"Kamiya","year":"2013","journal-title":"Bone"},{"issue":"38","key":"10.1016\/j.joca.2018.10.010_bib20","doi-asserted-by":"crossref","first-page":"25900","DOI":"10.1074\/jbc.M707692200","article-title":"Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT\/IkappaB kinase alpha pathway targeting activator protein-1","volume":"283","author":"Cahill","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.joca.2018.10.010_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.joca.2018.10.010_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bone.2009.03.665","article-title":"Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head","volume":"45","author":"Kim","year":"2009","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.joca.2018.10.010_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2106\/00004623-197860040-00005","article-title":"Arthrographic findings in Legg-Calve-Perthes disease and transient synovitis of the hip","volume":"60","author":"Gershuni","year":"1978","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.joca.2018.10.010_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bone.2010.10.006","article-title":"Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis","volume":"48","author":"Zhang","year":"2011","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.joca.2018.10.010_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00439-007-0354-y","article-title":"A\u00a0recurrent mutation in type II collagen gene causes Legg-Calve-Perthes disease in a Japanese family","volume":"121","author":"Miyamoto","year":"2007","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.joca.2018.10.010_bib26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/art.23491","article-title":"Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calve-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1","volume":"58","author":"Su","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.joca.2018.10.010_bib27","doi-asserted-by":"crossref","first-page":"e100505","DOI":"10.1371\/journal.pone.0100505","article-title":"A\u00a0novel p. Gly630Ser mutation of COL2A1 in a Chinese family with presentations of Legg-Calve-Perthes disease or avascular necrosis of the femoral head","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.joca.2018.10.010_bib28","first-page":"1319","article-title":"Downregulated SOX9 mediated by miR-206 promoted cell apoptosis in Legg-Calve-Perthes disease","volume":"15","author":"Luo","year":"2018","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.joca.2018.10.010_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.intimp.2015.08.044","article-title":"Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes","volume":"29","author":"Zhou","year":"2015","journal-title":"Int Immunopharm"},{"issue":"3","key":"10.1016\/j.joca.2018.10.010_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00501401","article-title":"Microspectrophotometric quantitation of glycosaminoglycans in articular cartilage sections stained with Safranin O","volume":"82","author":"Kiviranta","year":"1985","journal-title":"Histochemistry"},{"issue":"2","key":"10.1016\/j.joca.2018.10.010_bib31","first-page":"145","article-title":"Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model","volume":"16","author":"Wang","year":"2016","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"10.1016\/j.joca.2018.10.010_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1995-7645(14)60186-3","article-title":"Protective function of tocilizumab in human cardiac myocytes ischemia reperfusion injury","volume":"8","author":"Cheng","year":"2015","journal-title":"Asian Pac J Trop Med"},{"issue":"2","key":"10.1016\/j.joca.2018.10.010_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng0697-174","article-title":"SOX9 directly regulates the type-II collagen gene","volume":"16","author":"Bell","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.joca.2018.10.010_bib34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.biopha.2017.11.132","article-title":"MicroRNA-19a promotes cell viability and migration of chondrocytes via up-regulating SOX9 through NF-kappaB pathway","volume":"98","author":"Yu","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.joca.2018.10.010_bib35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2106\/00004623-200208000-00007","article-title":"Development of flattening and apparent fragmentation following ischemic necrosis of the capital femoral epiphysis in a piglet model","volume":"84-A","author":"Kim","year":"2002","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"12","key":"10.1016\/j.joca.2018.10.010_bib36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1359\/jbmr.040911","article-title":"Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis","volume":"19","author":"Kim","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"49","key":"10.1016\/j.joca.2018.10.010_bib37","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1073\/pnas.0407788101","article-title":"Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification","volume":"101","author":"Inada","year":"2004","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418315140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458418315140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:50:32Z","timestamp":1761018632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458418315140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1063458418315140"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2018.10.010","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}